Partnerships are an important component of our business plan. We have developed valuable relationships with world-class biotechnology and biopharmaceutical companies and have established research collaborations with distinguished academic investigators. Contact us today to learn more about our clinical programs or to find out how we can help you succeed with your antibody selection.
Collaboration Partner: Janssen Pharmaceutical Inc.
Research collaboration with Janssen R&D for the creation of novel anti-cancer agents.
Collaboration Partner: Five Prime Therapeutics, Inc.
Multi-target antibody discovery deal.
Collaboration Partner: Biocon Limited
Co-development collaboration in which Biocon and Vaccinex jointly discover, develop and commercialize therapeutic antibody products.
Collaboration Partner: Celldex Therapeutics, Inc.
Preclinical evaluation of VX15 with an immune costimulator in oncology.
Collaboration Partner: Tesaro, Inc.
Preclinical evaluation of VX15 with novel checkpoint inhibitors in oncology.
Collaboration Partner: NIH-NCI
Preclinical evaluation of VX15 with cancer vaccines in oncology.